Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23775185)

1.

Development of anti-influenza A compounds: a pilot study.

Zheng BJ, Chan CS, Poon KM, Ng F, Ho CM, Che CM, Yuen KY.

Hong Kong Med J. 2013 Jun;19 Suppl 4:36-8.

2.

Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.

Maddry JA, Chen X, Jonsson CB, Ananthan S, Hobrath J, Smee DF, Noah JW, Noah D, Xu X, Jia F, Maddox C, Sosa MI, White EL, Severson WE.

J Biomol Screen. 2011 Jan;16(1):73-81. doi: 10.1177/1087057110384613. Epub 2010 Nov 8.

PMID:
21059874
3.

[Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5N1 avian influenza virus].

Liu H, Zhang GL, Shen L, Zeng Z, Zhou BL, Liu CH, Nie G.

Zhong Xi Yi Jie He Xue Bao. 2010 Nov;8(11):1036-40. Chinese.

4.

Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues.

Uyeki TM.

Clin Infect Dis. 2009 Jul 15;49(2):279-90. doi: 10.1086/600035. Review.

5.

CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.

Liu S, Li R, Zhang R, Chan CC, Xi B, Zhu Z, Yang J, Poon VK, Zhou J, Chen M, Münch J, Kirchhoff F, Pleschka S, Haarmann T, Dietrich U, Pan C, Du L, Jiang S, Zheng B.

Eur J Pharmacol. 2011 Jun 25;660(2-3):460-7. doi: 10.1016/j.ejphar.2011.04.013. Epub 2011 Apr 22.

PMID:
21536025
6.

Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.

Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.

Peptides. 2011 Jul;32(7):1518-25. doi: 10.1016/j.peptides.2011.05.015. Epub 2011 May 19.

PMID:
21620914
7.

[Design of deoxyribozymes for inhibition of influenza A virus].

Evdokimov AA, Mazurkova NA, Malygin EG, Zarytova VF, Levina AS, Repkova MN, Zagrebelnyĭ SN, Netesova NA.

Mol Biol (Mosk). 2013 Jan-Feb;47(1):83-93. Russian.

PMID:
23705497
8.

D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.

Smee DF, Hurst BL, Day CW.

Antivir Chem Chemother. 2012 Aug 21;22(6):263-72. doi: 10.3851/IMP2105.

PMID:
22516927
9.

Heterocyclic compounds based on 3-(4-bromophenyl) azo-5-phenyl-2(3H)-furanone: anti-avian influenza virus (H5N1) activity.

Flefel EM, Abdel-Mageid RE, Tantawy WA, Ali MA, Amr Ael-G.

Acta Pharm. 2012 Dec;62(4):593-606. doi: 10.2478/v10007-012-0037-7.

PMID:
23333891
10.
11.

A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.

Ehrhardt C, Hrincius ER, Korte V, Mazur I, Droebner K, Poetter A, Dreschers S, Schmolke M, Planz O, Ludwig S.

Antiviral Res. 2007 Oct;76(1):38-47. Epub 2007 Jun 4.

PMID:
17572513
12.

Advances in the structure-based design of the influenza A neuraminidase inhibitors.

Mitrasinovic PM.

Curr Drug Targets. 2010 Mar;11(3):315-26. Review.

PMID:
20210756
13.

Avian influenza virus (H5N1) in human, Laos.

Puthavathana P, Sangsiriwut K, Korkusol A, Pooruk P, Auewarakul P, Pittayawanganon C, Sutdan D, Kitphati R, Sawanpanyalert P, Phommasack B, Bounlu K, Ungchusak K.

Emerg Infect Dis. 2009 Jan;15(1):127-9. doi: 10.3201/eid1501.080524. No abstract available.

14.

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Jun;54(6):2517-24. doi: 10.1128/AAC.01739-09. Epub 2010 Mar 29.

15.

Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection.

Komatsu T, Kido N, Sugiyama T, Yokochi T.

Immunopharmacol Immunotoxicol. 2013 Feb;35(1):1-7. doi: 10.3109/08923973.2012.710636. Epub 2012 Aug 3.

PMID:
22856509
16.

Antiviral activity of recombinant mouse β-defensin 3 against influenza A virus in vitro and in vivo.

Jiang Y, Yang D, Li W, Wang B, Jiang Z, Li M.

Antivir Chem Chemother. 2012 Aug 21;22(6):255-62. doi: 10.3851/IMP2077.

PMID:
22345365
17.

[Study of antiviral activity of extracts obtained from basidial fungi against influenza viruses of different subtypes in experiments in vitro and in vivo].

Kabanov AS, Kosogova TA, Shishkina LN, Tepliakova TV, Skarnovich MO, Mazurkova NA, Puchkova LI, Malkova EM, Stavskiĭ EA, Drozdov IG.

Zh Mikrobiol Epidemiol Immunobiol. 2011 Jan-Feb;(1):40-3. Russian.

PMID:
21449077
18.

Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives.

Selvam P, Murugesh N, Chandramohan M, Sidwell RW, Wandersee MK, Smee DF.

Antivir Chem Chemother. 2006;17(5):269-74.

PMID:
17176631
19.

Anti-H5N1 virus flavonoids from Capparis sinaica Veill.

Ibrahim AK, Youssef AI, Arafa AS, Ahmed SA.

Nat Prod Res. 2013;27(22):2149-53. doi: 10.1080/14786419.2013.790027. Epub 2013 May 7.

PMID:
23651316
20.

Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.

Brancato V, Peduto A, Wharton S, Martin S, More V, Di Mola A, Massa A, Perfetto B, Donnarumma G, Schiraldi C, Tufano MA, de Rosa M, Filosa R, Hay A.

Antiviral Res. 2013 Aug;99(2):125-35. doi: 10.1016/j.antiviral.2013.05.005. Epub 2013 May 22.

PMID:
23707194
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk